The National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for Long COVID in adults. The project expects to launch trials to test at least seven more treatments in coming months, informed by findings from its other research over the past two years.

“Recognizing that more than one solution is likely needed, we’ve taken the lessons learned from RECOVER participants to design rigorous clinical trial platforms that will identify treatments for persons with different symptom clusters to improve their function and well-being,” said Walter Koroshetz, M.D., director of the NIH’s National Institute of Neurological Disorders and Stroke.

In related news, the Department of Health and Human Services today officially launched its Office of Long COVID Research and Practice to coordinate and lead the federal response to Long COVID.
 

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…